K-D Balance is an FDA-cleared clinical assessment tool for athletic trainers and physical therapists, structured around accelerometer-based balance testing on iOS devices.
The App DNA
What makes this app unique?
The platform removes the subjectivity of manual balance observation, allowing professionals to track patient recovery longitudinally through objective, device-derived scores.
For Trained professionals including athletic trainers, physical therapists, nurses, and physicians conducting balance assessments.
What does it look like?
Key features
Derives a balance score using the device internal accelerometer to detect movement during three specific stances. Revenue Link: B2B / partnership — requires an existing account, functioning as a gate for professional clinical use.
Enables professionals to compare assessment results over time for individual patients. Revenue Link: Retention — provides clinical value that incentivizes continued use of the platform for patient monitoring.
How much does it cost?
The app functions as a B2B tool where access is gated by an existing professional account rather than direct in-app purchase.
Velocity
Maintenance developmentopaqueperformanceShow more...
K-D Balance maintains a low-frequency release cadence, shipping only two updates over the last six months. With a current update interval of 13 days since the latest release, the development trend remains firmly in the maintenance tier. The publisher provides opaque release notes for all recent builds, offering no insight into specific feature development or functional changes. The app currently relies on infrequent stability patches rather than active feature iteration.
Who built it?
King-Devick Test
3 apps tracked · Medical
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for K-D Balance
How's the Medical market?
K-D Balance operates as a specialized clinical instrument within the Medical category, maintaining a 3.67 rating across a small sample of professional users. The lack of direct in-app monetization signals that the platform prioritizes B2B account control over consumer-facing revenue.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for K-D Balance
Where is it heading?
The clinical assessment market is consolidating around objective, data-backed tools that integrate into existing professional workflows. K-D Balance is well-positioned to defend its niche as long as it maintains the integrity of its longitudinal tracking, as the cost for clinics to migrate patient data is high.
- The maintenance-only release cadence indicates a focus on stability over feature expansion, which aligns with the needs of a clinical B2B tool.
- FDA-cleared status provides a stable competitive position that general-purpose fitness apps cannot easily replicate without significant regulatory investment.
The SWOT
- FDA-cleared status functions as a B2B distribution barrier
- Longitudinal tracking creates high switching costs for clinics
- Remote-monitoring partnerships could increase longitudinal data utility
Next best moves
Maintain clinical data integrity because the FDA-cleared status is the primary B2B value driver → sustain professional trust.
+ 1 more prioritized moveThe counter-intuitive read
The maintenance-mode cadence is not a weakness but a clinical necessity…
Read the full takeBottom line
K-D Balance remains a specialized clinical utility, and its value rests on the reliability of its longitudinal data tracking. Prioritizing backend stability for clinical data integrity will defend the platform's professional-grade position against general-purpose entrants.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated